DEVELOPMENT - Custom Antibody Services: IMG-AbS™
ImmunoGenes produces monoclonal and polyclonal antibodies using our IMG-AbS™ platform technology. This patented technology allows us to produce high quality and diverse antibodies against challenging antigens. IMG-AbS™ is redefining the parameters of antibody production by offering highly customized antibodies that are difficult or impossible to generate using standard methods.
- A solution for difficult antigens
- Generates antibodies against weakly immunogenic antigens
- Produces highly diverse antibodies
- Generates a higher number of antigen specific B cells
- Breaks immune tolerance to highly conserved antigens
- Significantly improves hybridoma production
- Higher levels of circulating antibodies .